United Kingdom · Question · Written question
UIN 33282
Coronavirus: Screening
Introduced
14 July 2021
Last action
19 August 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
19 August 2021
Summary
To ask the Secretary of State for Health and Social Care, what the evidential basis was for the Medicines and Healthcare products Regulatory Agency to conclude that the concerns raised by the US Food and Drug Administration on the NHS rebranded Innova lat
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
14 July 2021
Written question
To ask the Secretary of State for Health and Social Care, what the evidential basis was for the Medicines and Healthcare products Regulatory Agency to conclude that the concerns raised by the US Food and Drug Administration on the NHS rebranded Innova lat
Source: Commons
19 August 2021
Answer
NHS Test and Trace have taken on the role of legal manufacturer of the self-tests which have been given a Medicines and Healthcare products Regulatory Agency (MHRA) Exceptional Use Authorisation (EUA) for the purpose of detection of COVID-19 in asymptomat...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-07-14/33282
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1346957
- uk · wq-1346957 · source updated 19 August 2021